HORIBA ABX PENTRA 400 I.S.E. Module, Model Numbers: P400ISE110EN02 and P400ISE110US02, All Serial...

FDA Device Recall #Z-1141-2013 — Class II — March 20, 2013

Recall Summary

Recall Number Z-1141-2013
Classification Class II — Moderate risk
Date Initiated March 20, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Horiba Instruments, Inc dba Horiba Medical
Location Irvine, CA
Product Type Devices
Quantity 905 units

Product Description

HORIBA ABX PENTRA 400 I.S.E. Module, Model Numbers: P400ISE110EN02 and P400ISE110US02, All Serial Numbers, Software Versions 5.0.7 and Below. Used to measure absorbance and ion electrodes.

Reason for Recall

HORIBA Medical is informing all ABX PENTRA 400 Analyzer with I.S.E. Module customers that there are no Linearity Limit Flags for the I.S.E. assays currently programmed into the ABX PENTRA 400 Analyzer software. All other assays run on this analyzer do have Linearity Limit Flags to alert the user to values that fall below or above the validated linearity range for each assay.

Distribution Pattern

Nationwide Distribution.

Lot / Code Information

Model Numbers: P400ISE110EN02 and P400ISE110US02. All Serial Numbers. Versions 5.0.7 and below

Other Recalls from Horiba Instruments, Inc dba Horiba Me...

Recall # Classification Product Date
Z-2286-2018 Class II ABX Pentra Micro ALBUMIN 2 CP, Serum/Plasma, RE... Apr 26, 2018
Z-0493-2018 Class II 10 ML REAGENT CUP, B1034626, SAP 1221034626 for... Nov 21, 2017
Z-0494-2018 Class II 15 ML REAGENT CUP, B1037307, SAP 1221037307 for... Nov 21, 2017
Z-0902-2015 Class II ABX PENTRA Reagent Container, Model No. B103730... Nov 13, 2014
Z-2692-2014 Class II ABX PENTRA Magnesium RTU Reagent, Part No. A11A... Aug 11, 2014

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.